GGHCX
Price
$37.99
Change
+$0.10 (+0.26%)
Updated
Sep 5 closing price
Net Assets
1.2B
THISX
Price
$80.31
Change
+$0.22 (+0.27%)
Updated
Sep 4 closing price
Net Assets
11.05B
Interact to see
Advertisement

GGHCX vs THISX

Header iconGGHCX vs THISX Comparison
Open Charts GGHCX vs THISXBanner chart's image
Invesco Health Care A
Price$37.99
Change+$0.10 (+0.26%)
VolumeN/A
Net Assets1.2B
T. Rowe Price Health Sciences I
Price$80.31
Change+$0.22 (+0.27%)
VolumeN/A
Net Assets11.05B
GGHCX vs THISX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GGHCX vs. THISX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGHCX is a Buy and THISX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
THISX has more cash in the bank: 11B vs. GGHCX (1.2B). THISX pays higher dividends than GGHCX: THISX (0.18) vs GGHCX (0.00). GGHCX was incepted earlier than THISX: GGHCX (36 years) vs THISX (9 years). GGHCX (1.05) is less costly to investors than THISX (0.67). GGHCX is a more actively managed with annual turnover of: 56.00 vs. THISX (52.40). GGHCX has a lower initial minimum investment than THISX: GGHCX (1000) vs THISX (500000). GGHCX annual gain was more profitable for investors over the last year : -9.22 vs. THISX (-19.94). THISX return over 5 years is better than : -9.26 vs. GGHCX (-9.85).
GGHCXTHISXGGHCX / THISX
Total Expense Ratio1.050.67157%
Annual Report Gross Expense Ratio1.050.67157%
Fund Existence36 years9 years-
Gain YTD6.8230.753906%
Front Load6%N/A-
Min. Initial Investment10005000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.2B11B11%
Annual Yield % from dividends0.000.18-
Returns for 1 year-9.22-19.9446%
Returns for 3 years16.69-7.46-224%
Returns for 5 years-9.85-9.26106%
Returns for 10 years-18.37N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GMALF0.45N/A
N/A
Genting Malaysia Berhad
RCDTF65.44N/A
N/A
Recordati Industria Chimica e Farmaceutica S.p.A.
BDRL0.03N/A
N/A
Blonder Tongue Laboratories, Inc.
NRPI0.08N/A
N/A
NRP Stone, Inc.
PRVFF3.77N/A
N/A
PRO REAL ESTATE INVT TR